Giving continuity to the first contract signed last February with the Cuban company Heberbiotec to introduce this Cuban biotechnology flag drug in Barbados, the executive director of Superior Pharmaceutical, Philip Springer, with the presence of one of its legal directors, Robert "Bobby" Clarke, during the Health International Convention, signed of a second contract with the Cuban Medical Services Holding (SMC) whereby two Cuban experts will carry out a one-year technical consultancy for the training of Barbadian personnel that will apply this treatment aimed at curing foot ulcers in patients diabetics thus avoiding amputation; the Ministry of Health of Barbados has been supporting both contracts since the public hospital Queen Elizabeth will be one of the main recipients of the Heberprot-P.